Clinical trial

Effects of Apelin on the Lung Circulation in Pulmonary Hypertension

NCT01457170

Study summary

ClinicalTrials.gov

Effects of Apelin on the Lung Circulation in Pulmonary Hypertension

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Apelin Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Saline (Placebo) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Apelin Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2012-01-01

PhaseNA

Conditions

Pulmonary Arterial Hypertensionverified · MONDO: pulmonary arterial hypertension

Heart Failureverified · MONDO: heart failure

Interventions

ApelinDRUG

Saline (Placebo)DRUG

ApelinDRUG

Sponsors & collaborators

Golden Jubilee National Hospitallead sponsor

NHS Lothiancollaborator

Imperial College Healthcare NHS Trustcollaborator

Mapped research locations

LondonUnited Kingdom1 GlasgowUnited Kingdom1 EdinburghUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01457170 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.